(Q40948245)

25 September 2017

1 reference

title

Treatment of the elderly patient with acute myeloid leukaemia (English)

1 reference

25 September 2017

1 reference

Löwenberg B

1

1 reference

25 September 2017

publication date

1 March 1996

1 reference

Best Practice and Research: Clinical Haematology

25 September 2017

published in

1 reference

25 September 2017

volume

9

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

147-159

1 reference

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Hematopoiesis and aging III: Anemia and a blunted erythropoietic response to hemorrhage in aged mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Population-based age- and sex-specific incidence rates in the 4 main types of leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

PROGNOSTIC VALUE OF CD34 EXPRESSION IN DE NOVO ACUTE MYELOBLASTIC LEUKAEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Acute myeloid leukaemia in the elderly: biology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Susceptibility of acute myeloid leukemia (AML) cells from clinically resistant and sensitive patients to daunomycin (DNR): assessment in vitro after stimulation with colony stimulating factors (CSFs).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980041-2

7 January 2021

10.1016/S0950-3536(96)80041-2

Identifiers

DOI

1 reference

release_qo4hkeeoubacvilu63u3vjvys4

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qo4hkeeoubacvilu63u3vjvys4

24 November 2022

mapped directly with Wikidata item

1 reference